Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02348398
Title Phase II Study of Pazopanib and Topotecan in Cervical Cancer
Recruitment Withdrawn
Gender female
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

cervical squamous cell carcinoma

cervical adenosquamous carcinoma

cervical adenocarcinoma

Therapies

Pazopanib + Topotecan

Age Groups: adult
Covered Countries


No variant requirements are available.